| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/19/2023 | 4.74% | Stifel | $71 → $80 | Maintains | Hold |
| 05/01/2023 | 7.36% | DA Davidson | $80 → $82 | Maintains | Buy |
| 04/28/2023 | 2.12% | Baird | $70 → $78 | Maintains | Neutral |
| 02/23/2023 | -21.45% | UBS | $58 → $60 | Maintains | Sell |
| 02/01/2023 | -7.04% | Stifel | $59 → $71 | Maintains | Hold |
| 02/01/2023 | -8.35% | Baird | $58 → $70 | Maintains | Neutral |
| 02/01/2023 | -9.66% | Citigroup | $63 → $69 | Maintains | Neutral |
| 01/20/2023 | -22.75% | Stifel | $58 → $59 | Maintains | Hold |
| 01/17/2023 | -14.9% | Loop Capital | $67 → $65 | Downgrades | Buy → Hold |
| 01/12/2023 | -27.99% | Goldman Sachs | $46 → $55 | Maintains | Sell |
| 01/10/2023 | -24.06% | UBS | $65 → $58 | Downgrades | Neutral → Sell |
| 12/09/2022 | -20.14% | Citigroup | $50 → $61 | Maintains | Neutral |
| 10/19/2022 | -14.9% | DA Davidson | $75 → $65 | Maintains | Buy |
| 10/11/2022 | -26.68% | Stifel | $63 → $56 | Maintains | Hold |
| 08/08/2022 | -14.9% | UBS | $64 → $65 | Maintains | Neutral |
| 07/29/2022 | -14.9% | Citigroup | $61 → $65 | Maintains | Neutral |
| 07/20/2022 | -24.06% | Stifel | $59 → $58 | Maintains | Hold |
| 07/18/2022 | -1.81% | Northcoast Research | → $75 | Initiates Coverage On | → Buy |
| 07/14/2022 | -21.45% | Baird | $72 → $60 | Downgrades | Outperform → Neutral |
| 07/06/2022 | -7.04% | Longbow Research | → $71 | Upgrades | Neutral → Buy |
| 05/20/2022 | -16.21% | UBS | $85 → $64 | Maintains | Neutral |
| 05/18/2022 | -5.73% | Baird | $79 → $72 | Maintains | Outperform |
| 04/29/2022 | -22.75% | Stifel | $73 → $59 | Maintains | Hold |
| 04/21/2022 | -14.9% | Loop Capital | $92 → $65 | Maintains | Buy |
| 04/18/2022 | -4.43% | Stifel | $80 → $73 | Maintains | Hold |
| 01/28/2022 | 4.74% | Stifel | $81 → $80 | Maintains | Hold |
| 01/27/2022 | 4.74% | CFRA | $76 → $80 | Maintains | Hold |
| 01/06/2022 | 11.29% | UBS | $75 → $85 | Maintains | Neutral |
| 12/20/2021 | 17.83% | Jefferies | $80 → $90 | Maintains | Hold |
| 11/22/2021 | 30.92% | Loop Capital | → $100 | Initiates Coverage On | → Buy |
| 10/29/2021 | -1.81% | UBS | $73 → $75 | Maintains | Neutral |
| 10/11/2021 | -9.66% | Stifel | $72 → $69 | Maintains | Hold |
| 10/05/2021 | 11.29% | Baird | $82 → $85 | Upgrades | Neutral → Outperform |
| 08/04/2021 | -4.43% | UBS | $72 → $73 | Maintains | Neutral |
| 07/30/2021 | -1.81% | Stifel | $72 → $75 | Maintains | Hold |
| 07/16/2021 | 15.21% | Rosenblatt | $85 → $88 | Maintains | Buy |
| 07/12/2021 | -5.73% | UBS | $70 → $72 | Maintains | Neutral |
| 05/13/2021 | -8.35% | UBS | $62 → $70 | Maintains | Neutral |
| 05/03/2021 | 11.29% | Rosenblatt | $78 → $85 | Maintains | Buy |
| 04/30/2021 | -47.63% | Goldman Sachs | $35 → $40 | Maintains | Sell |
| 04/05/2021 | -12.28% | Stifel | $65 → $67 | Downgrades | Buy → Hold |
| 03/03/2021 | -18.83% | UBS | $60 → $62 | Maintains | Neutral |
| 02/01/2021 | -5.73% | Rosenblatt | $65 → $72 | Maintains | Buy |
| 01/20/2021 | -14.9% | Stifel | $64 → $65 | Maintains | Buy |
| 10/30/2020 | -14.9% | Rosenblatt | $62 → $65 | Maintains | Buy |
| 10/13/2020 | -21.45% | UBS | $54 → $60 | Downgrades | Buy → Neutral |
| 10/01/2020 | -24.06% | Stifel | $53 → $58 | Maintains | Buy |
| 09/17/2020 | -18.83% | Rosenblatt | $47 → $62 | Upgrades | Neutral → Buy |
| 08/17/2020 | -27.99% | Jefferies | $45 → $55 | Maintains | Hold |
| 08/03/2020 | -38.47% | Rosenblatt | $48 → $47 | Maintains | Neutral |
| 06/24/2020 | -37.16% | Rosenblatt | $45 → $48 | Maintains | Neutral |
| 06/18/2020 | — | CFRA | Upgrades | Strong Sell → Hold | |
| 06/17/2020 | -35.85% | Baird | $45 → $49 | Maintains | Neutral |
| 05/29/2020 | -29.3% | UBS | → $54 | Initiates Coverage On | → Buy |
| 05/15/2020 | -41.08% | Rosenblatt | $44 → $45 | Maintains | Neutral |
| 05/07/2020 | -47.63% | Stephens & Co. | $37 → $40 | Maintains | Equal-Weight |
| 05/07/2020 | -42.39% | Rosenblatt | $41 → $44 | Maintains | Neutral |
| 05/06/2020 | -38.47% | Stifel | $45 → $47 | Maintains | Buy |
| 05/06/2020 | — | Boenning & Scattergood | Upgrades | Neutral → Outperform | |
| 05/06/2020 | -58.1% | CFRA | $39 → $32 | Maintains | Strong Sell |
| 05/06/2020 | -41.08% | Baird | $39 → $45 | Maintains | Neutral |
| 04/03/2020 | -41.08% | Stifel | → $45 | Initiates Coverage On | → Buy |
| 02/26/2020 | -37.16% | Rosenblatt | $51 → $48 | Maintains | Neutral |
| 02/26/2020 | -50.25% | Stephens & Co. | $44 → $38 | Maintains | Equal-Weight |
| 02/26/2020 | -41.08% | Baird | $53 → $45 | Downgrades | Outperform → Neutral |
| 01/30/2020 | — | Northcoast Research | Downgrades | Buy → Neutral | |
| 01/29/2020 | -30.61% | Baird | $54 → $53 | Maintains | Outperform |
| 12/09/2019 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 12/06/2019 | -43.7% | Goldman Sachs | → $43 | Initiates Coverage On | → Sell |
| 11/06/2019 | -31.92% | Rosenblatt | → $52 | Initiates Coverage On | → Neutral |
| 10/30/2019 | -27.99% | Baird | $54 → $55 | Maintains | Outperform |
| 05/20/2019 | — | Edward Jones | Downgrades | Buy → Hold | |
| 05/16/2019 | -21.45% | Baird | → $60 | Maintains | Outperform |
| 05/01/2019 | -20.14% | DA Davidson | $59 → $61 | Maintains | Buy |
| 05/01/2019 | -21.45% | Baird | $62 → $60 | Maintains | Outperform |
| 05/01/2019 | — | Boenning & Scattergood | Downgrades | Outperform → Neutral | |
| 04/10/2019 | -18.83% | Baird | $56 → $62 | Maintains | Outperform |
| 03/12/2019 | -21.45% | Keybanc | $53 → $60 | Maintains | Overweight |
| 01/30/2019 | -27.99% | SunTrust Robinson Humphrey | $58 → $55 | Maintains | Buy |
| 01/30/2019 | -34.54% | Stephens & Co. | $45 → $50 | Maintains | Equal-Weight |
| 01/30/2019 | -30.61% | BMO Capital | → $53 | Downgrades | Outperform → Market Perform |
| 11/27/2018 | -30.61% | Keybanc | → $53 | Upgrades | Sector Weight → Overweight |
| 11/20/2018 | -34.54% | Stephens & Co. | → $50 | Initiates Coverage On | → Equal-Weight |
| 10/31/2018 | -13.59% | BMO Capital | $73 → $66 | Maintains | Outperform |
| 10/10/2018 | -24.06% | Baird | $68 → $58 | Maintains | Outperform |
What is the target price for A.O. Smith (AOS)?
The latest price target for A.O. Smith (NYSE: AOS) was reported by Stifel on July 19, 2023. The analyst firm set a price target for $80.00 expecting AOS to rise to within 12 months (a possible 4.74% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for A.O. Smith (AOS)?
The latest analyst rating for A.O. Smith (NYSE: AOS) was provided by Stifel, and A.O. Smith maintained their hold rating.
When is the next analyst rating going to be posted or updated for A.O. Smith (AOS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of A.O. Smith, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for A.O. Smith was filed on July 19, 2023 so you should expect the next rating to be made available sometime around July 19, 2024.
Is the Analyst Rating A.O. Smith (AOS) correct?
While ratings are subjective and will change, the latest A.O. Smith (AOS) rating was a maintained with a price target of $71.00 to $80.00. The current price A.O. Smith (AOS) is trading at is $76.38, which is within the analyst's predicted range.